Examples of achievements

Medtech seminar  November 2025

Medical Lead's CEO Robert Harju-Jeanty gave an open seminar on Medtech for Biocat in Barcelona, now for the tenth time.

www.biocat.cat/en/programs/short-program-life-sciences

Evaluator of EIT Health  January 2025

Robert Harju-Jeanty was for the fifth time invited as expert evaluator of EU's grant applications of EIT Health, this time for Medtech in the Flagship Call.

https://eithealth.eu

New drug enters Finland   July 2024

Medical Lead's customer Grifols brings a new subcutaneous immunoglobulin, Xembify^® to the Finnish market with support from Medical Lead Nordic. This will help patients suffering from primary immunodeficiency.

https://fimea.fi/en/databases_and_registers/fimeaweb?query=Xembify&humanmed=true&selfcare=true&receptmed=true&marketedmed=true&prefillonly=false

AgeTech market study and webinar  February 2023

Medical Lead finalised a study of the Swedish AgeTech market on the assignment of Business Finland to support Finnish companies to enter the Swedish market.

Webinar on internationalisation   January 2022

Medical Lead Nordic AB gave togehter with KTH a second webinar on the internationalisation roadmap for Medtech companies, assigned by Medtech4Health and Vinnova.

https://medtech4health.se/internationalisering/spelplan/